Search alternatives:
significant interventions » significant interactions (Expand Search), significant interaction (Expand Search), significant alterations (Expand Search)
interventions based » interventions aimed (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 41 - 60 results of 39,941 for search '(( significant interventions based ) OR ( significant ((clinical decrease) OR (linear decrease)) ))', query time: 1.49s Refine Results
  1. 41
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  2. 42
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  3. 43
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  4. 44
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  5. 45
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  6. 46
    Brain regions with significantly decreased activations for the Raven task are shown in blue.

    Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

    Published 2025
    Save to List
    Saved in:
  7. 47
    Statistically significant linear increase in use of antidepressants during the observed time period.

    Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  8. 48
    Clinical significance of <i>STM</i><sub><i>FCS</i></sub>.

    Clinical significance of <i>STM</i><sub><i>FCS</i></sub>. by Peter A. Pahapill (8468607)

    Published 2020
    Save to List
    Saved in:
  9. 49
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 50
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 51
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 52
    Baseline clinical characteristics and laboratory data of eligible patients in valve replacement or valvuloplasty.

    Baseline clinical characteristics and laboratory data of eligible patients in valve replacement or valvuloplasty. by Yuki Asai (15190606)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 53
    Baseline clinical characteristics and laboratory data of eligible patients in pre- and post-PBPM.

    Baseline clinical characteristics and laboratory data of eligible patients in pre- and post-PBPM. by Yuki Asai (15190606)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 54
    Variants with an unknown significance or conflicting interpretation of clinical significance.

    Variants with an unknown significance or conflicting interpretation of clinical significance. by J. Tyson McDonald (3687694)

    Published 2022
    Save to List
    Saved in:
  15. 55
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 56
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 57
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Comparison of FOC scores in intervention and control groups at baseline, after 8 weeks and after childbirth.

    Comparison of FOC scores in intervention and control groups at baseline, after 8 weeks and after childbirth. by Sahar Khademioore (17319385)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 59
    Pearson’s product moment correlations between study measures.

    Pearson’s product moment correlations between study measures. by Arianna Prudenzi (12436789)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 60
    Psychological distress (GHQ-12) scores (and standard errors).

    Psychological distress (GHQ-12) scores (and standard errors). by Arianna Prudenzi (12436789)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: